Pulmonary hypertension associated with use of Phentermine

Yonsei Medical Journal

Volumn 51, Issue 6, 2010, Pages 971-973

  Bang, Woo Dae ^a   Kim, Ji Ye ^a   Yu, Hee Tae ^a   Cho, Sung Soo ^a   Jang, Ji Yong ^a   Oh, Chang Myung ^a   Joung, Boyoung ^a   Chang, Hyuk Jae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Phentermine; Pulmonary hypertension

Indexed keywords

AMINOREX; BOSENTAN; CHLORPHENTERMINE; DIURETIC AGENT; FENFLURAMINE; METHAMPHETAMINE; PHENTERMINE;

ADULT; ARTICLE; CASE REPORT; DRUG STRUCTURE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; LIVER FUNCTION TEST; MORNING DOSAGE; OBESITY; PULMONARY HYPERTENSION; TACHYCARDIA; THORAX RADIOGRAPHY;

ADULT; ANTIHYPERTENSIVE AGENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MODELS, CHEMICAL; OBESITY; PHENTERMINE; RADIOGRAPHY, THORACIC; SAFETY; SULFONAMIDES;

EID: 77957939555     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.6.971     Document Type: Article

References (17)

1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Causespecific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-37.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105.
3. Mark EJ, Patalas ED, Chang HT, Evans RJ, Kessler SC. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med 1997;337:602-6.
4. Dillon KA, Putnam KG, Avorn JL. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine. JAMA 1997;278:1320.
5. Schembre DB, Boynton KK. Appetite-suppressant drugs and primary pulmonary hypertension. N Engl J Med 1997;336:510-1; author reply 512-3.
6. Goldstein SE, Levy Y, Shoenfeld Y. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. Harefuah 1998;135:489-92, 568.
7. Tellier P. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts. Ann Med Interne (Paris) 2001;152:429-36.
8. Weissman NJ. Appetite suppressants and valvular heart disease. Am J Med Sci 2001;321:285-91.
9. Sachdev M, Miller WC, Ryan T, Jollis JG. Effect of fenfluraminederivative diet pills on cardiac valves: a meta-analysis of observational studies. Am Heart J 2002;144:1065-73.
10. Wellman PJ, Maher TJ. Synergistic interactions between fenfluramine and phentermine. Int J Obes Relat Metab Disord 1999;23:723-32.
11. Roth JD, Rowland NE. Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats. Psychopharmacology (Berl) 1998;137:99-106.
12. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest 2000;117:870-4.
13. Schnabel KH, Schulz V, Busch S, Just H. [Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course]. Med Welt 1976;27:1300-3.
14. Backmann R, Dengler H, Gahl K, Greiser E, Jesdinsky HJ, Loogen F. [Primary pulmonary hypertension. Report of the Commission of the German Society for Research on Blood Circulation]. Verh Dtsch Ges Kreislaufforsch 1972;38:134-41.
15. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 2002;26:262-73.
16. Eddahibi S, Adnot S. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Respir Res 2002;3:9.
17. Rothman RB, Ayestas MA, Dersch CM, Baumann MH. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 1999;100:869-75.